Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ribo-seq of Eif6 WT and Eif6 S235A Mouse Embryonic Fibroblasts (MEFs) pre-treated with harringtonine

ABSTRACT: Analysis of global variability of translation initiation between the Eif6 WT control genotype and the Eif6 S235A mutated MEF lines pre-treated with harringtonine. Ribosome Protected Fragments (RPFs) were obtained following the method reported in Ingolia NT et al., NatProtoc 2012. (doi:10.1038/nprot.2012.086)

INSTRUMENT(S): NextSeq 2000

ORGANISM(S): Mus musculus

SUBMITTER:

PROVIDER: E-MTAB-13335 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP151032

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Ribo-seq of Eif6 WT and Eif6 S235A Mouse Embryonic Fibroblasts (MEFs)

Project description:Analysis of global variability of translation between the Eif6 WT control genotype and the Eif6 S235A mutated MEF lines. Ribosome Protected Fragments (RPFs) were obtained followwing the procedure reported in McGlincy NJ & Ingolia NT. Methods. 2017 (doi: 10.1016/j.ymeth.2017.05.028).

2026-02-10 | E-MTAB-13319 | biostudies-arrayexpress

Ribo-seq of Eif6 WT and Eif6 S235A Mouse Embryonic Fibroblasts (MEFs)

Project description:Analysis of global variability of translation between the Eif6 WT control genotype (CTRL) and the Eif6 S235A (SA) mutated MEF lines. The analysis is done on three replicates per genotype. Ribosome Protected Fragments (RPFs) were obtained following the procedure reported in McGlincy NJ & Ingolia NT. Methods. 2017 (doi: 10.1016/j.ymeth.2017.05.028).

2026-02-10 | E-MTAB-14299 | biostudies-arrayexpress

40S footprints of Eif6 WT and Eif6 S235A MEFs

Project description:Analysis of 40S ribosome profiling of Eif6 WT and Eif6 S235A MEFs

2026-02-10 | E-MTAB-14860 | biostudies-arrayexpress

Ribo-seq of Eif6 WT, Eif6 S235A, Eif6 S235A rescued with eIF6WT and high salt treated MEFs

Project description:Analysis of global variability of translation in all conditions. Ribosome Protected Fragments (RPFs) were obtained following the procedure reported in McGlincy NJ & Ingolia NT. Methods. 2017 (doi: 10.1016/j.ymeth.2017.05.028). Samples labelled with \"HS\" were treated with 0.5M of KCl before digestion.

2026-02-10 | E-MTAB-14864 | biostudies-arrayexpress

RNA-seq of Eif6 WT and Eif6 S235A Mouse Embryonic Fibroblasts (MEFs)

Project description:Analysis of the global variability of gene expression between the Eif6 WT control genotype (CTRL) and the Eif6 S235A mutated (SA) MEF lines. To analyze the effects over time of the lack of Eif6 phosphorylation, we transduced MEFs with tamoxifen-inducible Cre, so that treatment leads to excision of wild-type exons and the generation of cells bearing the S235A mutation. The analysis is done on three replicates per genotype.

2026-02-10 | E-MTAB-14304 | biostudies-arrayexpress

RNA-seq of liver biopsies of eIF6 wild type and eIF6 heterozygous mice

Project description:A cohort of age-matched mice (eIF6+/+ and eIF6+/-) were fed with High-Fat Diet. All experimental mice were sacrificed after 16 weeks and the livers were recovered. RNA was isolated from liver biopsies of eIF6+/+ and eIF6+/- mice and RNAseq analysis was performed. The aim of the analysis is the investigation of the transcriptional changes driven by chronic depletion of eIF6 in the liver of mice upon High Fat Diet (HFD) feeding.

2021-06-18 | E-MTAB-9009 | biostudies-arrayexpress

RNA-seq of Eif6 WT and Eif6 S235A Mouse Embryonic Fibroblasts (MEFs)

Project description:Analysis of the global variability of gene expression between the Eif6 WT control genotype and the Eif6 S235A mutated MEF lines. To analyze the effects over time of the lack of Eif6 phosphorylation, we transduced MEFs with tamoxifen-inducible Cre, so that treatment leads to excision of wild-type exons and the generation of cells bearing the S235A mutation. RNA-seq analyses were performed on samples collected at the time of tamoxifen addition (T0), 48 hours (T1), and 72 hours (T2) after the treatment.

2026-02-10 | E-MTAB-13343 | biostudies-arrayexpress

40S footprints of Eif6 WT and Eif6 S235A MEFs

Project description:40S footprints of Eif6 WT and Eif6 S235A MEFs

| PRJEB86007 | ENA

Reduced EIF6 dosage attenuates TP53 activation in models of Shwachman-Diamond syndrome

Project description:Shwachman-Diamond syndrome (SDS) is characterized by neutropenia, exocrine pancreatic insufficiency, and bony abnormalities with an increased risk of myeloid neoplasia. Almost all cases of SDS result from biallelic mutations in SBDS. SBDS interacts with EFL1 to displace EIF6 from the 60S ribosomal subunit. Released EIF6 permits the assembly of ribosomal large and small subunits in the cytoplasm. Decreased EIF6 levels due to haploinsufficiency or missense mutations which lead to decreased protein expression may provide a somatic genetic rescue and anti-leukemic effects. We observed accumulation of EIF6 protein in sbds knockout (KO) zebrafish models, confirmed in patient-derived tissues, and correlated with changes in ribosome proteins and TP53 pathways. The mechanism of action for this adaptive response is unknown. To address this, we generated an eif6 zebrafish KO line which do not survive past 10 days post fertilization. We also created two mutants with low Eif6 expression, 5-25% of the wildtype levels, that can survive until adulthood. We bred them with sbds-null strains and analyzed their phenotype and biochemical properties. Low Eif6 levels reduced Tp53 pathway activation but did not rescue neutropenia in Sbds-deficient zebrafish. Further studies elucidating the interplay between SBDS, EIF6, TP53, and cellular stress responses offer promising insights into SDS pathogenesis, somatic genetic rescue, and therapeutic strategies.

2025-04-01 | GSE282310 | GEO

Skeletal muscle of Eif6 heterozygous mice

Project description:Tibialis anterior and gastrocnemius muscle from Eif6 heterozygous mice and wild-type mice profiled using Agilent gene expression arrays

2018-07-07 | GSE116709 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data